Developing Novel Endpoints for Paediatric Clinical Trials with Digital Health Technology - David Nobbs, PhD, International Regulatory Policy Lead for Digital Health and Data Policy, Roche
Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
Please visit us at [ Ссылка ]
Ещё видео!